Non-canonical MAPK signaling in yeast
酵母中的非典型 MAPK 信号传导
基本信息
- 批准号:10681246
- 负责人:
- 金额:$ 32.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnaphaseAnimalsApoptosisBindingBinding ProteinsBiochemistryBiological ModelsCell CycleCell NucleusCellsCellular biologyChromosome SegregationComplexCongenital AbnormalityCoupledCouplesCouplingCuesCyclic AMP-Dependent Protein KinasesCytoplasmDataDevelopmentDiseaseDown-RegulationEnzymesEukaryotaEventFamilyG0 PhaseGerm CellsGlucansHealthHumanLife Cycle StagesLinkLobeMAPK8 geneMalignant NeoplasmsMediatingMeiosisMembraneMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensModelingMolecular ConformationMolecular GeneticsNuclearPathway interactionsPhasePhosphorylationPhosphotransferasesProcessPropertyProteinsRNA Recognition MotifRegulationReproduction sporesResearchSaccharomyces cerevisiaeSignal PathwaySignal TransductionSpecificityStimulusTestingThreonineTimeTyrosineYeastsanaphase-promoting complexcell growthcyclin-dependent kinase-activating kinaseenvironmental stressorhuman diseaseinhibitorinsightlink proteinp38 Mitogen Activated Protein Kinasepreventprogramsrecruitsegregationspatiotemporalubiquitin-protein ligase
项目摘要
Project Summary/Abstract: Mitogen activated protein kinases (MAPKs) are a family of
conserved signaling enzymes that are dysregulated in numerous human diseases. Many
MAPKs are activated in canonical signaling pathways by MAPK kinases. This
mechanism of activation has been well-studied. Other MAPKs are activated in non-
canonical signaling pathways by binding proteins that trigger autophosphorylation of the
MAPK. Relatively little is known about this mechanism of activation and how it is
regulated. The yeast Saccharomyces cerevisiae is a powerful model system in which to
study MAPK signaling. Smk1 is a meiosis-specific MAPK in yeast that is activated in a
non-canonical pathway by a binding protein, Ssp2, as the meiotic divisions are being
completed. Smk1 then controls the post-meiotic program of gamete (spore) formation by
phosphorylating regulatory substrates. The anaphase promoting complex (APC) E3
ubiquitin-ligase is a key regulator of chromosome segregation. The APC also plays a
role in coupling the differentiation of animal cells to the G1/G0 phase of the cell-cycle.
The APC is required for Ssp2 to activate Smk1 yet the mechanism linking the APC to
MAPK activation was until recently unknown. In preliminary data, Isc10 has been
identified as an inhibitory protein that links the APC to Smk1 activation. A working model
for this pathway posits that Isc10 forms a complex with Smk1 and Ssp2 in the cytoplasm
of meiotic cells that is poised for activation. In this model, the poised ternary complex is
imported into nuclei, where the nuclear resident APC, complexed with a meiosis-specific
targeting subunit, Ama1, triggers ubiquitylation of Isc10 after anaphase of meiosis II.
This allows Ssp2 to activate the intramolecular autophosphorylation of Smk1, thereby
activating the MAPK and coupling spore differentiation to the completion of nuclear
segregation. To test and extend this model we will: 1- Elucidate how the inhibitor protein
Isc10 controls Smk1 activation, 2- Decipher the spatiotemporal regulation that links
MAPKs to the APC, 3- Determine how activated Smk1 controls post-meiotic processes.
Insights from these studies will be broadly relevant to mechanisms that control MAPK
signaling in the context of developmental programs and how the APC couples
differentiation programs to the cell-cycle in higher eukaryotes.
项目概要/摘要:丝裂原活化蛋白激酶(MAPK)是一个家族,
在许多人类疾病中失调的保守信号酶。许多
MAPK在经典信号通路中被MAPK激酶激活。这
活化机制已得到充分研究。其他的MAPK在非-
典型的信号通路通过结合蛋白,触发自磷酸化的
MAPK。关于这种激活机制及其原理,人们知之甚少
监管.酵母酿酒酵母是一个强大的模型系统,其中,
研究MAPK信号通路。Smk 1是酵母中减数分裂特异性MAPK,在细胞分裂中被激活。
结合蛋白Ssp 2通过非经典途径,因为减数分裂正在进行,
完成然后Smk 1通过以下方式控制配子(孢子)形成的减数分裂后程序
磷酸化调节底物。后期促进复合物(APC)E3
泛素连接酶是染色体分离的关键调节因子。APC还发挥着
在将动物细胞的分化与细胞周期的G1/G 0期偶联中的作用。
Ssp 2激活Smk 1需要APC,但将APC与Smk 1连接的机制不清楚。
MAPK的激活直到最近才为人所知。在初步数据中,Isc 10已经被
被鉴定为将APC与Smk 1激活联系起来的抑制性蛋白。一个工作模型
对于该途径,假定Isc 10与Smk 1和Ssp 2在细胞质中形成复合物
准备激活的减数分裂细胞在这个模型中,平衡的三元复合物是
导入细胞核,其中细胞核常驻APC,与减数分裂特异性
靶向亚基Ama 1在减数分裂后期II触发Isc 10的泛素化。
这使得Ssp 2能够激活Smk 1的分子内自磷酸化,从而
激活MAPK,将孢子分化与核分裂完成偶联,
隔离。为了测试和扩展这个模型,我们将:1-阐明如何抑制蛋白
Isc 10控制Smk 1激活,2-解密时空调节,
MAPKs的APC,3-确定如何激活Smk 1控制减数分裂后的过程。
从这些研究中获得的见解将与控制MAPK的机制广泛相关
在发展计划的背景下,以及APC如何耦合
在高等真核生物的细胞周期分化程序。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isc10, an inhibitor of the Smk1 MAPK, prevents activation loop autophosphorylation and substrate phosphorylation through separate mechanisms.
- DOI:10.1016/j.jbc.2022.102450
- 发表时间:2022-10
- 期刊:
- 影响因子:4.8
- 作者:Rimal, Abhimannyu;Swayne, Thomas M.;Kamdar, Zeal P.;Tewey, Madison A.;Winter, Edward
- 通讯作者:Winter, Edward
RNA Recognition-like Motifs Activate a Mitogen-Activated Protein Kinase.
RNA 识别样基序激活丝裂原激活蛋白激酶。
- DOI:10.1021/acs.biochem.8b01032
- 发表时间:2018
- 期刊:
- 影响因子:2.9
- 作者:Phillips,Timothy;Tio,ChongWai;Omerza,Gregory;Rimal,Abhimannyu;Lokareddy,RaviK;Cingolani,Gino;Winter,Edward
- 通讯作者:Winter,Edward
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD P WINTER其他文献
EDWARD P WINTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD P WINTER', 18)}}的其他基金
PROTEIN KINASE NETWORKS AND SPORULATION IN S. CEREVISIAE
酿酒酵母中的蛋白激酶网络和孢子形成
- 批准号:
7990577 - 财政年份:2009
- 资助金额:
$ 32.14万 - 项目类别:
PROTEIN KINASE NETWORKS AND SPORULATION IN S. CEREVISIAE
酿酒酵母中的蛋白激酶网络和孢子形成
- 批准号:
7103651 - 财政年份:2000
- 资助金额:
$ 32.14万 - 项目类别:
PROTEIN KINASE NETWORKS AND SPORULATION IN S. CEREVISIAE
酿酒酵母中的蛋白激酶网络和孢子形成
- 批准号:
6900259 - 财政年份:2000
- 资助金额:
$ 32.14万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 32.14万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 32.14万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 32.14万 - 项目类别: